Scholars Central

Review articlePublished 23 Jul 2016

Alitretinoin for the treatment of chronic hand eczema: clinical rationale

Authors: Vivian Y Shi, Raja K Sivamani & Howard Maibach

Clinical Investigation

Volume 4 · Issue 8 · Pages 763–773

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic hand eczema (CHE), an inflammatory skin disease, places heavy psychosocial and economic burden on the affected individual and society as a whole. Patch testing is recommended to identify potential causative allergens in each patient. Efficacy of traditional topical treatments render the management of CHE challenging. Oral alitretinoin (9-cis-retinoic acid) is a new drug for the treatment of severe, refractory CHE. This review summarizes the advances on oral alitretinoin for the treatment of severe CHE, with emphasis on its particular benefit for hyperkeratotic hand eczema, and discusses pharmacodynamics and pharmacokinetics, clinical trials and knowledge gaps.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Investigation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Vivian Y Shi”
  • BylineArticles whose byline prints “Raja K Sivamani & Howard Maibach”